About Us
Investor Relations
Corporate Profile
Calendar
Presentations
Press Releases
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Insider Transactions
Financial Information
SEC Filings
Financial Reports
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Email Alerts
Newsroom
Marketed Products
ARCALYST
®
(rilonacept)
Clinical Pipeline
Aflibercept (VEGF Trap)
VEGF Trap - Eye
Rilonacept (IL-1 Trap)
Research Focus Areas
Angiogenesis
Oncology
Ophthalmology
Cardiovascular Diseases
Immunity and Inflammation
Infectious Diseases
Metabolic Diseases and Obesity
Muscle Disorders
Pain
Bone Disease
Research Publications
Technology Platforms
VelociGene
®
VelociMouse
®
VelocImmune
®
Antibodies
Traps
Protein Production
VelociMab™
Industrial Capabilities
Careers
Contact Us
Site Map
SEARCH
Printed Materials
To receive printed material by postal mail, please complete the following form.
*
Fields are Required
Please send me
*
Document
Request
View Online
Investor Kit
N/A
2008 Annual Report & 10-K
N/A
First name
*
Last name
*
Email
*
Title
Company
Profile
*
Please Select
Individual Investor
Equity Analyst (sell-side)
Equity Analyst (buy-side)
Fixed Income Analyst (sell-side)
Fixed Income Analyst (buy-side)
Portfolio Manager (Equity)
Portfolio Manager (Fixed Income)
Broker/Investment Advisor
Banker/Financing Source
Press/Media
Consultant
Employee
Customer/Client
Library/Reference
Student
Other
Address
*
City
*
State/province
*
Postal code
*
Country
*
Shipment method
Postal Mail
DHL
Federal Express
Federal Express Priority
UPS Next Day Air
Account number
Required for express delivery
Telephone
Home
Fax
Work
Extension
Type in number
*
This helps Regeneron Pharmaceuticals, Inc. prevent automated submissions.
I am interested in receiving investor relations notifications. **
** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.
Print page
Email page
Stock Information
NASDAQ:REGN
$25.78
+ 0.13
Mar 10, 2010
4:00 PM ET
Quotes delay at least 20min., by eSignal.
3 Mo.
6 Mo.
1 Yr.
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
REGN Snapshot
RSS News Feeds
Search Investor Relations
Investor site
Section only
Featured Report
2008
Annual Report
2008
Form 10-K
2009
Form 10-Q
2009
Proxy Statement